ANIK: Anika Therapeutics Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-31 | Fell below 5% | Vanguard Capital Management | 4.95% | SEC |
Institutional ownership (Q2 2026)
133 institutions reported holding $170.71M of Anika Therapeutics Inc on Form 13F (130 the quarter before). 17 opened a new position and 12 sold out. Shares held by institutions: same.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 1,449,671 | $21.21M |
| Caligan Partners LP | 1,435,130 | $21.00M |
| MORGAN STANLEY | 614,320 | $8.99M |
| VANGUARD CAPITAL MANAGEMENT LLC | 572,113 | $8.37M |
| AQR CAPITAL MANAGEMENT LLC | 559,846 | $8.19M |
| BOOTHBAY FUND MANAGEMENT, LLC | 529,640 | $7.75M |
| RENAISSANCE TECHNOLOGIES LLC | 481,417 | $7.04M |
| DIMENSIONAL FUND ADVISORS LP | 451,095 | $6.60M |
| CAPITAL MANAGEMENT CORP /VA | 448,474 | $6.56M |
| DEUTSCHE BANK AG\ | 353,552 | $5.17M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.